Sun Pharmaceutical Industries (SUNPHARMA) Share Price Falls 2.35%: What Sun Pharmaceutical Industries Share Price Shows Today

Sun Pharmaceutical Industries Share Price fell 2.35% to Rs 1,727.50, and the company’s market capitalisation stood at Rs 4,22,067.01 crore as of 14 October 2026 at 1:23:13 PM IST. The latest move places Sun Pharmaceutical Industries Share Price among the sharper single-day declines in the session so far, while keeping the company in the Large Cap category. Univest data confirms the move itself, though no company-specific trigger has been identified. For readers tracking Sun Pharmaceutical Industries Share Price Today, the move is relevant because it came after the stock opened at the previous close and then moved lower within a narrow intraday range. Univest data also shows that the stock’s valuation and operating ratios remain central to the discussion around Sun Pharmaceutical Industries Share Price and Sun Pharmaceutical Industries Stock News today.

For investors following Sun Pharmaceutical Industries Share Price, the key question is not only what changed in the tape, but how the move fits the company’s broader fundamental and sector context. The latest Univest figures show a Large Cap healthcare name with a sizeable market capitalisation, a premium valuation versus much of the same-industry set, and profitability ratios that remain above benchmark medians. That mix makes Sun Pharmaceutical Industries Share Price Today important for stock analysis, fundamental analysis and sector comparison rather than for any short-term price narrative alone.

Sun Pharmaceutical Industries (SUNPHARMA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,727.5
Previous Close	Rs 1,769.1
Today's Move	-Rs 41.60 (-2.35%)
Open	Rs 1,769.1
High	Rs 1,777.05
Low	Rs 1,725.7
Market Capitalisation	Rs 4,22,067.01 crore
Market Cap Category	Large Cap

Sun Pharmaceutical Industries Share Price opened at Rs 1,769.10, matched the previous close at the open, touched a high of Rs 1,777.05 and a low of Rs 1,725.70 before last trading at Rs 1,727.50. The stock was down Rs 41.60 or 2.35% from the previous close of Rs 1,769.10. In market-cap terms, Sun Pharmaceutical Industries remains a Large Cap company with Rs 4,22,067.01 crore. The day’s range shows that Sun Pharmaceutical Industries Share Price moved lower after the open and stayed near the lower end of the band as of 14 October 2026 at 1:23:13 PM IST. For Sun Pharmaceutical Industries Share Price Today, that is the core price event: a clear decline in a large healthcare company, with no additional catalyst established by Univest data. From here, the more useful question is what Sun Pharmaceutical Industries Share Price says in relation to the company’s fundamentals.

Sun Pharmaceutical Industries (SUNPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 4,22,067.01 crore
P/E Ratio	35.09x
P/B Ratio	4.91x
ROE	14.85%
ROCE	19.11%
EPS	Rs 50.41
Book Value Per Share	Rs 360.44
Dividend Yield	0.9%

Sun Pharmaceutical Industries (SUNPHARMA) fundamental metrics show P/E 35.09x, P/B 4.91x, ROE 14.85%, ROCE 19.11%. Read together, these ratios describe the company's position rather than a recommendation.

Sun Pharmaceutical Industries has a market capitalisation of Rs 4,22,067.01 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 35.09x, P/B at 4.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.85% and ROCE of 19.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 50.41, book value per share of Rs 360.44, dividend yield of 0.9%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.72x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	35.09x
Benchmark Median P/E	31.72x
Benchmark Average P/E	46.74x
Benchmark P/E Range	3.11x to 663.29x
Company P/B Ratio	4.91x
Benchmark Median P/B	2.91x
Benchmark Average P/B	4.27x
Company ROE	14.85%
Benchmark Median ROE	11.61%
Benchmark Average ROE	10.59%
Company ROCE	19.11%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.35%
Company Market Capitalisation	Rs 4,22,067.01 crore
Benchmark Median Market Cap	Rs 821.94 crore
Benchmark Average Market Cap	Rs 13,782.64 crore

Sun Pharmaceutical Industries (SUNPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Sun Pharmaceutical Industries (SUNPHARMA) has a P/E ratio of 35.09x, which is above the benchmark median of 31.72x, a difference of +10.62%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Sun Pharmaceutical Industries (SUNPHARMA) has a ROE of 14.85%, which is above the benchmark median of 11.61%, a difference of +27.91%. Sun Pharmaceutical Industries (SUNPHARMA) has a ROCE of 19.11%, which is above the benchmark median of 13.46%, a difference of +41.98%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Divi's Laboratories	DIVISLAB	2,48,982.98	84.18	13.94	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,77,974.12	80.83	19.64	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,13,615.69	25	4.18	19.69	21.39
Laurus Labs	LAURUSLABS	1,11,898.66	101.36	19.65	18.31	18.2
Cipla	CIPLA	1,06,129.96	31.88	3.06	11.83	16

Sun Pharmaceutical Industries (SUNPHARMA) has a P/E ratio of 35.09x compared with the displayed peer median of 80.83x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 14.85% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.11% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sun Pharmaceutical Industries (SUNPHARMA) has a market capitalisation of Rs 4,22,067.01 crore. It is larger by market capitalisation than all 5 peers shown.

Why Investors Are Watching Sun Pharmaceutical Industries

• Sun Pharmaceutical Industries Share Price fell 2.35% today to Rs 1,727.50, making the intraday move worth tracking closely.
• The company remains a Large Cap name with a market capitalisation of Rs 4,22,067.01 crore.
• Sun Pharmaceutical Industries Share Price carries a P/E of 35.09 and a P/B of 4.91, both relevant in valuation review.
• ROE of 14.85% and ROCE of 19.11% remain above the same-industry medians.
• The Healthcare and Pharmaceuticals & Drugs context keeps Sun Pharmaceutical Industries Share Price in focus against listed peers.

About Sun Pharmaceutical Industries

Sun Pharmaceutical Industries operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical products and related healthcare offerings, and it is positioned as a Large Cap business in the Indian market. For Sun Pharmaceutical Industries Share Price, this business profile matters because the stock is often assessed through its earnings power, asset base and valuation rather than only through daily price changes. In Univest’s framing, Sun Pharmaceutical Industries Share Price reflects a business that is large enough to be benchmarked against the broader industry universe while still trading with its own return and valuation profile.

Track Sun Pharmaceutical Industries Share Price on Univest

Use Sun Pharmaceutical Industries (SUNPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Sun Pharmaceutical Industries Share Price on Univest for live updates, fundamental ratios, 52-week levels and market insights in one place. The platform also helps readers follow Sun Pharmaceutical Industries Stock News, Sun Pharmaceutical Industries Share Price Today and Sun Pharmaceutical Industries Fundamental Analysis without switching between different sources. For investors comparing valuation, the stock page keeps the main company metrics together.

Frequently Asked Questions

Why did Sun Pharmaceutical Industries Share Price fall today?

Ans. Sun Pharmaceutical Industries Share Price fell 2.35% to Rs 1,727.50. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move is best read through price action and valuation context.

What is Sun Pharmaceutical Industries Share Price today?

Ans. Sun Pharmaceutical Industries Share Price last traded at Rs 1,727.50 as of 14 October 2026 at 1:23:13 PM IST. It was down Rs 41.60 from the previous close of Rs 1,769.10.

Is Sun Pharmaceutical Industries a Large Cap company?

Ans. Yes. Sun Pharmaceutical Industries Share Price belongs to a Large Cap company with a market capitalisation of Rs 4,22,067.01 crore. That scale places it well above the benchmark industry median and average.

What does Sun Pharmaceutical Industries valuation show?

Ans. Sun Pharmaceutical Industries Share Price reflects a P/E of 35.09 and a P/B of 4.91. Those figures sit above the same-industry medians, so the stock trades at a premium to many peers on these measures.

How do Sun Pharmaceutical Industries ROE and ROCE compare?

Ans. Sun Pharmaceutical Industries Share Price is backed by ROE of 14.85% and ROCE of 19.11%. Both are above the same-industry benchmark medians, which gives the stock a stronger profitability profile than many peers.

What is Sun Pharmaceutical Industries EPS and book value?

Ans. Sun Pharmaceutical Industries Share Price is associated with EPS of Rs 50.41 and book value of Rs 360.44. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

How does Sun Pharmaceutical Industries compare with peers?

Ans. Sun Pharmaceutical Industries Share Price sits below several high-multiple peers such as Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs on P/E. Its market cap is the largest among the named peers, which sets it apart in scale.

What sector does Sun Pharmaceutical Industries belong to?

Ans. Sun Pharmaceutical Industries Share Price is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The stock is measured against a same-industry benchmark of 199 companies in the latest Univest data.

Should investors track Sun Pharmaceutical Industries Share Price today?

Ans. Sun Pharmaceutical Industries Share Price is worth tracking because it combines a large market capitalisation, a premium valuation profile and profitability ratios above benchmark medians. That mix keeps Sun Pharmaceutical Industries Stock News relevant for investors.